Gregersen NT, Moller BK, Raben A, Kristensen ST, Holm L, Flint A et al
Our three guests were: Svetlana Mojsov, who is a pioneer in the study of this crucial hormone and whose research has been instrumental in the development of GLP-1 receptor agonists Richard DiMarchi, whose academic expertise and work within the pharmaceutical industry has played a pivotal role in advancing both the scientific understanding and clinical application of GLP-1 therapies Stefan Trapp, who leads a research group that investigates the physiological functions of GLP-1 and its potential as a therapeutic target for metabolic diseases Speakers Svetlana Mojsov Svetlana Mojsov is a research associate professor at Rockefeller University, US
This is a standard limitation of blend research and is why the peer-reviewed literature on individual components, rather than blend-specific data, is the primary reference for KLOW safety profiling
Receptor expression Cell surface expression of GIPR, GLP-1R and GCGR were determined by flow cytometry 24 h post-transfection in HEK293T cells